CONTEXT: Smaller hippocampal volumes are well established in posttraumatic stress disorder (PTSD), but the relatively few studies of amygdala volume in PTSD have produced equivocal results. OBJECTIVE: To assess a large cohort of recent military veterans with PTSD and trauma-exposed control subjects, with sufficient power to perform a definitive assessment of the effect of PTSD on volumetric changes in the amygdala and hippocampus and of the contribution of illness duration, trauma load, and depressive symptoms. DESIGN: Case-controlled design with structural magnetic resonance imaging and clinical diagnostic assessments. We controlled statistically for the important potential confounds of alcohol use, depression, and medication use. SETTING: Durham Veterans Affairs Medical Center, which is located in proximity to major military bases. PATIENTS: Ambulatory patients (n = 200) recruited from a registry of military service members and veterans serving after September 11, 2001, including a group with current PTSD (n = 99) and a trauma-exposed comparison group without PTSD (n = 101). MAIN OUTCOME MEASURE: Amygdala and hippocampal volumes computed from automated segmentation of high-resolution structural 3-T magnetic resonance imaging. RESULTS: Smaller volume was demonstrated in the PTSD group compared with the non-PTSD group for the left amygdala (P = .002), right amygdala (P = .01), and left hippocampus (P = .02) but not for the right hippocampus (P = .25). Amygdala volumes were not associated with PTSD chronicity, trauma load, or severity of depressive symptoms. CONCLUSIONS: These results provide clear evidence of an association between a smaller amygdala volume and PTSD. The lack of correlation between trauma load or illness chronicity and amygdala volume suggests that a smaller amygdala represents a vulnerability to developing PTSD or the lack of a dose-response relationship with amygdala volume. Our results may trigger a renewed impetus for investigating structural differences in the amygdala, its genetic determinants, its environmental modulators, and the possibility that it reflects an intrinsic vulnerability to PTSD.
CONTEXT: Smaller hippocampal volumes are well established in posttraumatic stress disorder (PTSD), but the relatively few studies of amygdala volume in PTSD have produced equivocal results. OBJECTIVE: To assess a large cohort of recent military veterans with PTSD and trauma-exposed control subjects, with sufficient power to perform a definitive assessment of the effect of PTSD on volumetric changes in the amygdala and hippocampus and of the contribution of illness duration, trauma load, and depressive symptoms. DESIGN: Case-controlled design with structural magnetic resonance imaging and clinical diagnostic assessments. We controlled statistically for the important potential confounds of alcohol use, depression, and medication use. SETTING: Durham Veterans Affairs Medical Center, which is located in proximity to major military bases. PATIENTS: Ambulatory patients (n = 200) recruited from a registry of military service members and veterans serving after September 11, 2001, including a group with current PTSD (n = 99) and a trauma-exposed comparison group without PTSD (n = 101). MAIN OUTCOME MEASURE: Amygdala and hippocampal volumes computed from automated segmentation of high-resolution structural 3-T magnetic resonance imaging. RESULTS: Smaller volume was demonstrated in the PTSD group compared with the non-PTSD group for the left amygdala (P = .002), right amygdala (P = .01), and left hippocampus (P = .02) but not for the right hippocampus (P = .25). Amygdala volumes were not associated with PTSD chronicity, trauma load, or severity of depressive symptoms. CONCLUSIONS: These results provide clear evidence of an association between a smaller amygdala volume and PTSD. The lack of correlation between trauma load or illness chronicity and amygdala volume suggests that a smaller amygdala represents a vulnerability to developing PTSD or the lack of a dose-response relationship with amygdala volume. Our results may trigger a renewed impetus for investigating structural differences in the amygdala, its genetic determinants, its environmental modulators, and the possibility that it reflects an intrinsic vulnerability to PTSD.
Authors: Jon D Elhai; Lucas de Francisco Carvalho; Fabiano Koich Miguel; Patrick A Palmieri; Ricardo Primi; B Christopher Frueh Journal: J Anxiety Disord Date: 2010-11-13
Authors: Ruth A Lanius; Chris R Brewin; J Douglas Bremner; Judith K Daniels; Matthew J Friedman; Israel Liberzon; Alexander McFarlane; Paula P Schnurr; Lisa Shin; Murray Stein; Eric Vermetten Journal: J Psychiatry Neurosci Date: 2010-03 Impact factor: 6.186
Authors: Jonathan Savitz; Allison C Nugent; Wendy Bogers; Alice Liu; Rebecca Sills; David A Luckenbaugh; Earle E Bain; Joseph L Price; Carlos Zarate; Husseini K Manji; Dara M Cannon; Sean Marrett; Dennis S Charney; Wayne C Drevets Journal: Neuroimage Date: 2009-11-17 Impact factor: 6.556
Authors: Rajendra A Morey; Elizabeth S Selgrade; Henry Ryan Wagner; Scott A Huettel; Lihong Wang; Gregory McCarthy Journal: Hum Brain Mapp Date: 2010-11 Impact factor: 5.038
Authors: Rajendra A Morey; Ahmad R Hariri; Andrea L Gold; Michael A Hauser; Heidi J Munger; Florin Dolcos; Gregory McCarthy Journal: BMC Psychiatry Date: 2011-05-05 Impact factor: 3.630
Authors: J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg Journal: Psychol Bull Date: 2014-11-03 Impact factor: 17.737
Authors: Rajendra A Morey; Courtney C Haswell; Stephen R Hooper; Michael D De Bellis Journal: Neuropsychopharmacology Date: 2015-07-14 Impact factor: 7.853
Authors: Chadi G Abdallah; Lynnette A Averill; Teddy J Akiki; Mohsin Raza; Christopher L Averill; Hassaan Gomaa; Archana Adikey; John H Krystal Journal: Annu Rev Pharmacol Toxicol Date: 2018-09-14 Impact factor: 13.820
Authors: Amy Badura-Brack; Timothy J McDermott; Katherine M Becker; Tara J Ryan; Maya M Khanna; Daniel S Pine; Yair Bar-Haim; Elizabeth Heinrichs-Graham; Tony W Wilson Journal: Psychiatry Res Neuroimaging Date: 2017-11-14 Impact factor: 2.376
Authors: Kristen M Wrocklage; Lynnette A Averill; J Cobb Scott; Christopher L Averill; Brian Schweinsburg; Marcia Trejo; Alicia Roy; Valerie Weisser; Christopher Kelly; Brenda Martini; Ilan Harpaz-Rotem; Steven M Southwick; John H Krystal; Chadi G Abdallah Journal: Eur Neuropsychopharmacol Date: 2017-03-06 Impact factor: 4.600
Authors: Mouna Maroun; Pericles J Ioannides; Krista L Bergman; Alexandra Kavushansky; Andrew Holmes; Cara L Wellman Journal: Eur J Neurosci Date: 2013-05-28 Impact factor: 3.386